GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).
For 69-year-old Andre Price, living with an enlarged prostate was affecting every part of his life. "I was getting up every hour and a half," Price says of having to wake frequently to use the ...
Benign Prostatic Hyperplasia (BPH), or enlarged prostate, is a common condition affecting millions of men, especially those over 50. It can lead to uncomfortable urinary symptoms and significantly ...
REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in surgical robotics, announced today that it has ...
FLORENCE — McLeod Regional Medical Center is the first hospital in South Carolina to perform the Aquablation Therapy procedure for the treatment of lower urinary tract symptoms due to benign prostatic ...
Providence Saint John’s Health Center is now equipped to offer Aquablation therapy, a state-of-the-art robotic procedure to treat men with enlarged prostates. The condition, if left untreated, can ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that the safety ...
Medicare Part B covers Aquablation for BPH if a person meets specific eligibility criteria, including a prostate volume of 30 to 150 cubic centimeters (cc). Medicare does not cover Aquablation in ...
The pros and cons of aquablation and HoLEP differ for benign prostate hyperplasia treatment. (HealthDay News) — For men with benign prostate hyperplasia, aquablation provides temporary benefits for ...
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
Scottsdale, Ariz.-based East Valley Urology has completed the first three prostate cancer procedures in PROCEPT BioRobotics’ FDA-approved WATER IV trial using Aquablation therapy. The outpatient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback